PGE2 synthesis and signaling in the liver physiology and pathophysiology: An update
Authors:
- 16 July 2024
- journal article
- research article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 174, 106875
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without CirrhosisJAMA, 2024
- Regulation of liver regeneration by prostaglandin E2 and thromboxane A2 following partial hepatectomy in ratsNaunyn-Schmiedeberg's Archives of Pharmacology, 2020
- Protective Role of Hepatocyte Cyclooxygenase‐2 Expression Against Liver Ischemia–Reperfusion Injury in MiceHepatology, 2019
- Prostaglandin E2 promotes hepatic bile acid synthesis by an E prostanoid receptor 3‐mediated hepatocyte nuclear receptor 4α/cholesterol 7α‐hydroxylase pathway in miceHepatology, 2016
- Natural History of Nonalcoholic Fatty Liver DiseaseDigestive Diseases and Sciences, 2016
- Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes #Hepatology, 2009
- Prostaglandin I2 and E2 mediate the protective effects of cyclooxygenase-2 in a mouse model of immune-mediated liver injuryHepatology, 2006
- COX‐2 induction in mice with experimental nutritional steatohepatitisHepatology, 2006
- Significance and Therapeutic Potential of Prostaglandin E2 Receptor in Hepatic Ischemia/Reperfusion Injury in Mice *Hepatology, 2005
- Kupffer cell prostaglandin-E2 production is amplified during hepatic regenerationHepatology, 1991